GH Shares Calculator
Enter either the number of shares you'd like to purchase OR the total investment you'd like to make.
shares x $15.98 = $159.8
GH Charts
GH Prices
View the GH historical prices.
52WL $15.89
The 52 Week Low is $15.89 set on Wed, Feb 28, 2024.
52WH $41.06
The 52 Week High is $41.06 set on Wed, Aug 30, 2023. The current price, $15.98, is 0% below the 52 Week High.
ATH $181.07
The All-Time High is $181.07 set on Fri, Feb 12, 2021. The current price, $15.98, is 0% below the All Time High.
52 Week Range
GH Dividends
GH has no dividend history.
0.00%
Annual Dividend Yield
$
Quarterly Dividend Rate
--
Declaration Date
--
Ex-Dividend Date
--
Record Date
--
Payment Date
--
Dividend Frequency
0
Dividend History
GH Profile
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
